Congenic analysis of the NKT cell control gene Nkt2 implicates the peroxisomal protein Pxmp4

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3400-3412

  Fletcher, Julie M ^a   Jordan, Margaret A ^a   Snelgrove, Sarah L ^b   Slattery, Robyn M ^b   Dufour, François D ^a   Kyparissoudis, Konstantinos ^c   Besra, Gurdyal S ^d   Godfrey, Dale I ^c   Baxter, Alan G ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CYTOKINE; GLYCOLIPID; MEMBRANE PROTEIN; NKT 1 PROTEIN; NKT 2 PROTEIN; PEROXIN 19; PEROXISOME ASSOCIATED INTEGRAL MEMBRANE PROTEIN; PROTEIN; PXMP 4 PROTEIN; UNCLASSIFIED DRUG; CD1 ANTIGEN; PXMP4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONGENIC STRAIN; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MICROARRAY ANALYSIS; MOUSE; NATURAL KILLER T CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; PEROXISOME; PRIORITY JOURNAL; THYMOCYTE; ANIMAL; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE COUNT; NATURAL KILLER CELL;

ANIMALS; ANTIGENS, CD1; CYTOKINES; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION PROFILING; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MEMBRANE PROTEINS; MICE; MICE, CONGENIC; MICE, INBRED NOD; PEROXISOMES;

EID: 51549118539     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3400     Document Type: Article

References (51)

1. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
2. Van Kaer, L. 2005. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5: 31-42. (Pubitemid 40070329)
3. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Ann. Rev. Immunol. 22: 817-890. (Pubitemid 38680443)
4. - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46: 572-582.
5. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187: 1047-1056.
6. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13. (Pubitemid 10185796)
7. Baxter, A. G., A. C. Horsfall, D. Healey, P. Ozegbe, S. Day, and D. G. Williams, A. Cooke. 1994. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 83: 227-231.
8. Silveira, P. A., and A. G. Baxter. 2001. The NOD mouse as a model of SLE. Autoimmunity 34: 53-64.
9. Esteban, L. M., T. Tsoutsman, M. A. Jordan, D. Roach, L. D. Poulton, A. Brooks, O. V. Naidenko, S. Sidobre, D. I. Godfrey, and A. G. Baxter. 2003. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J. Immunol. 171: 2873-2878.
10. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.
11. Jordan, M. A., P. A. Silveira, D. P. Shepherd, C. Chu, S. J. Kinder, J. Chen, L. J. Palmisano, L. D. Poulton, and A. G. Baxter. 2000. Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J. Immunol. 165: 1673-1684.
12. Jordan, M. A., J. M. Fletcher, D. Pellicci, and A. G. Baxter. 2007. Slamf1, the NKT cell control gene Nkt1. J. Immunol. 178: 1618-1627.
13. Nichols, K. E., C. S. Ma, J. L. Cannons, P. L. Schwartzberg, and S. G. Tangye. 2005. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203: 180-199. (Pubitemid 40179702)
14. Wang, N., A. Satoskar, W. Faubion, D. Howie, S. Okamoto, S. Feske, C. Gullo, K. Clarke, M. R. Sosa, A. H. Sharpe, and C. Terhorst. 2004. The cell surface receptor SLAM controls T cell and macrophage functions. J. Exp. Med. 199: 1255-1264. (Pubitemid 38620262)
15. Wu, C., K. B. Nguyen, G. C. Pien, N. Wang, C. Gullo, D. Howie, M. R. Sosa, M. J. Edwards, P. Borrow, A. R. Satoskar, et al. 2001. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat. Immunol. 2: 410-414. (Pubitemid 33706138)
16. Czar, M. J., E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, and P. L. Schwartzberg. 2001. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA 98: 7449-7454.
17. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. M. Bridgett, and E. H. Leiter. 1994. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin dependent diabetes resistance gene. J. Exp. Med. 180: 1553-1558.
18. Fox, C. J., A. D. Paterson, S. M. Mortin-Toth, and J. S. Danska. 2000. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am. J. Hum. Genet. 67: 67-81.
19. Naggert, J. K., J. L. Mu, W. Frankel, D. W. Bailey, and B. Paigen. 1995. Genomic analysis of the C57BL/Ks mouse strain. Mamm. Genome 6: 131-133.
20. 2-microglobulin. J. Immunol. 160: 1472-1478.
21. 2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc. Natl. Acad. Sci. USA 98: 11533-11538.
22. Hammond, K. J., D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167: 1164-1173.
23. Poulton, L. D., M. J. Smyth, C. G. Hawke, P. Silveira, D. Shepherd, O. V. Naidenko, D. I. Godfrey, and A. G. Baxter. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13: 887-896.
24. + CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
25. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555.
26. Sacksteder, K. A., J. M. Jones, S. T. South, X. Li, Y. Liu, and S. J. Gould. 2000. PEX19 binds multiple peroxisomal membrane proteins, is predominantly cytoplasmic, and is required for peroxisome membrane synthesis. J. Cell Biol. 148: 931-944.
27. Zhou, D., C. Cantu 3rd, Y. Sagiv, N. Schrantz, A. B. Kulkarni, X. Qi, D. J. Mahuran, C. R. Morales, G. A. Grabowski, K. Benlagha, et al. 2004. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303: 523-527.
28. Kang, S. J., and P. Cresswell. 2004. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 5: 175-181.
29. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789. (Pubitemid 39601398)
30. Sagiv, Y., K. Hudspeth, J. Mattner, N. Schrantz, R. K. Stern, D. Zhou, P. B. Savage, L. Teyton, and A. Bendelac. 2006. Cutting edge: Impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J. Immunol. 177: 26-30. (Pubitemid 43939110)
31. Gadola, S. D., J. D. Silk, A. Jeans, P. A. Illarionov, M. Salio, G. S. Besra, R. Dwek, T. D. Butters, F. M. Platt, and V. Cerundolo. 2006. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 203: 2293-2303.
32. Sango, K., M. P. McDonald, J. N. Crawley, M. L. Mack, C. J. Tifft, E. Skop, C. M. Starr, A. Hoffmann, K. Sandhoff, K. Suzuki, and R. L. Proia. 1996. Mice lacking both subunits of lysosomal β-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat. Genet. 14: 348-352.
33. Loftus, S. K., J. A. Morris, E. D. Carstea, J. Z. Gu, C. Cummings, A. Brown, J. Ellison, K. Ohno, M. A. Rosenfeld, D. A. Tagle, et al. 1997. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277: 232-235. (Pubitemid 27446077)
34. Rocha-Campos, A. C., R. Melki, R. Zhu, N. Deruytter, D. Damotte, M. Dy, A. Herbelin, and H. J. Garchon. 2006. Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Vα14-NKT cell performance but failure to protect against type 1 diabetes. Diabetes 55: 1163-1170.
35. Novak, J., L. Beaudoin, T. Griseri, and A. Lehuen. 2005. Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J. Immunol. 174: 1954-1961. (Pubitemid 40223936)
36. Reguenga, C., M. E. Oliveira, A. M. Gouveia, C. Eckerskorn, C. Sa-Miranda, J. E. Azevedo. 1999. Identification of a 24 kDa intrinsic membrane protein from mammalian peroxisomes. Biochim. Biophys. Acta 1445: 337-341. (Pubitemid 29298040)
37. de Duve, C. 1969. The peroxisome: a new cytoplasmic organelle. Proc. R. Soc. Lond. B Biol. Sci. 173: 71-83.
38. Rest, R. F., M. H. Cooney, and J. K. Spitznagel. 1978. Subcellular distribution of glycosidases in human polymorphonuclear leucocytes. Biochem. J. 174: 53-59. (Pubitemid 8378827)
39. Prigozy, T. I., O. Naidenko, P. Qasba, D. Elewaut, L. Brossay, A. Khurana, T. Natori, Y. Koezuka, A. Kulkarni, and M. Kronenberg. 2001. Glycolipid antigen processing for presentation by CD1d molecules. Science 291: 664-667.
40. Szatmari, I., A. Pap, R. Ruhl, J. X. Ma, P. A. Illarionov, G. S. Besra, E. Rajnavolgyi, B. Dezso, and L. Nagy. 2006. PPARγ controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 203: 2351-2362. (Pubitemid 44498369)
41. Szatmari, I., P. Gogolak, J. S. Im, B. Dezso, E. Rajnavolgyi, and L. Nagy. 2004. Activation of PPARγ specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21: 95-106. (Pubitemid 38925270)
42. Titorenko, V. I., and R. A. Rachubinski. 2004. The peroxisome: orchestrating important developmental decisions from inside the cell. J. Cell Biol. 164: 641-645.
43. Chinetti-Gbaguidi, G., E. Rigamonti, L. Helin, A. L. Mutka, M. Lepore, J. C. Fruchart, V. Clavey, E. Ikonen, S. Lestavel, and B. Staels. 2005. Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages. J. Lipid Res. 46: 2717-2725. (Pubitemid 43107484)
44. Schedin, S., P. J. Sindelar, P. Pentchev, U. Brunk, and G. Dallner. 1997. Peroxisomal impairment in Niemann-Pick type C disease. J. Biol. Chem. 272: 6245-6251. (Pubitemid 27118096)
45. Giabbai, B., S. Sidobre, M. D. Crispin, Y. Sanchez-Ruiz, A. Bachi, M. Kronenberg, I. A. Wilson, and M. Degano. 2005. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation. J. Immunol. 175: 977-984. (Pubitemid 41094982)
46. Rauch, J., J. Gumperz, C. Robinson, M. Skold, C. Roy, D. C. Young, M. Lafleur, D. B. Moody, M. B. Brenner, C. E. Costello, and S. M. Behar. 2003. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278: 47508-47515. (Pubitemid 37523193)
47. Wanders, R. J. 2004. Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol. Genet. Metab. 83: 16-27. (Pubitemid 39311277)
48. Stossel, T. P., R. J. Mason, T. D. Pollard, M. Vaughan. 1972. Isolation and properties of phagocytic vesicles: II. Alveolar macrophages. J. Clin. Invest. 51: 604-614.
49. Rogovin, V. V., R. A. Murav'ev, and V. M. Mushtakova. 2001. Composition of neutrophilic peroxisomes. Biol. Bull. 28: 329-334.
50. Monastyrska, I., and D. J. Klionsky. 2006. Autophagy in organelle homeostasis: peroxisome turnover. Mol. Aspects Med. 27: 483-494. (Pubitemid 44466655)
51. Pinto, M. P., C. P. Grou, I. S. Alencastre, M. E. Oliveira, C. Sa-Miranda, M. Fransen, and J. E. Azevedo. 2006. The import competence of a peroxisomal membrane protein is determined by Pex19p before the docking step. J. Biol. Chem. 281: 34492-133502